Welcome to the ESID 2022 Meeting Interactive Programme
The meeting will officially run on Central European Summer Time (CEST)
Session Description
This Moderna sponsored symposium will explore mRNA technology within the context of vaccine development and its role in protecting patients with immunodeficiencies. The session will be chaired by Professo Karin Loré, who, along with our expert faculty, will consider the challenges experienced by patients with immunodeficiencies in response to viral infections and the role of vaccination in addressing these challenges. Dr Paolo Martini will first introduce mRNA science and platform technology, considering its use in development of a vaccine for COVID-19, as well as the potential of mRNA therapeutics in other areas such as rare diseases. Dr Kimberley Gilmour will then familiarise us with the impact of primary immunodeficiencies on the immune system and the subsequent susceptibility to viral infections. She will share her insights on the burden, prevention, and management of respiratory and non-respiratory diseases in patients with primary immunodeficiencies. Finally, the response of patients with primary immunodeficiencies to vaccines, lessons learnt from mRNA COVID-19 vaccines, and guidance on vaccination in these patients will be addressed by Professor Paul Moss. The symposium will conclude with a live Q&A session with the faculty moderated by Professor Loré.